This is the SSRI case out of the Eastern District of Pennsylvania in which the court found most claims preempted both against a generic and against a pioneer drug manufacturer. The appeal was delayed to coordinate it with the McNellis case out of the District of New Jersey (an adverse preemption ruling being appealed interlocutorily).

Third Circuit oral argument has been scheduled for September 17, 2007.